Using a randomized controlled trial, measure the effect of a multi-component quality improvement intervention (training in communication & workflow optimization and delivery of monthly feedback on vaccine rates) on maternal flu and Tdap vaccination rates at participating OB/GYN sites.
- Centers for Disease Control and Prevention (CDC)
Participating Health Systems
- University of Rochester Medical Center (URMC)
- Rochester Regional Health (RRH)
- University of California, Los Angeles (UCLA)
- Los Angeles County Department of Health Services (LADHS)
- Phase 1: Utilizing eRecord data extraction as well as interview and survey tools, measure a) baseline maternal flu and Tdap vaccination coverage and b) provider knowledge, attitudes and behaviors regarding maternal flu and Tdap vaccination at participating OB/GYN practice sites (all participating locations).
- Phase 2: After randomizing participating sites (practice-level) to either the control or intervention cohort, implement and measure the effect of a quality improvement (QI) intervention aimed at improving maternal flu and Tdap vaccination rates. Intervention site personnel will:
- receive training (i.e., an online learning module and live meeting with project staff) regarding the severity of flu and pertussis, the safety and efficacy of the related vaccine, and optimal vaccine communication and workflow techniques.
- receive monthly vaccine rate feedback.
- complete 12 monthly PDSA cycles in which they implement small changes to their daily communication/workflow in an effort to increase vaccine uptake.
- Phase 3: Analyze intervention site and control site data across both baseline and intervention timeframes. If found to be effective, disseminate intervention tools as appropriate (e.g., online learning module, vaccine rate feedback template) to control sites. Measure cost-effectiveness of the intervention.